A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy

Summary

This is a Phase 1, single-site, interventional clinical trial evaluating the safety and efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.

Timeline

Start

2020-10-10

Primary completion

2021-09-20

Completion

2021-09-20

Drugs

Indications